R5K

N~1~-{(3R)-1-[2-(5-carbamimidamidopentanamido)ethyl]-1-azaspiro[5.5]undecan-3-yl}-N~2~-(4-chlorophenyl)ethanediamide

Created:	2022-06-20
Last modified:	2023-01-11

Find Related PDB Entry
1 entries where R5K is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	77
Chiral Atom Count	1
Bond Count	79
Aromatic Bond Count	6

2D diagram of R5K

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	N~1~-{(3R)-1-[2-(5-carbamimidamidopentanamido)ethyl]-1-azaspiro[5.5]undecan-3-yl}-N~2~-(4-chlorophenyl)ethanediamide
Systematic Name (OpenEye OEToolkits)	~{N}'-[(3~{R})-1-[2-(5-carbamimidamidopentanoylamino)ethyl]-1-azaspiro[5.5]undecan-3-yl]-~{N}-(4-chlorophenyl)ethanediamide
Formula	C₂₆ H₄₀ Cl N₇ O₃
Molecular Weight	534.094
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	12.01	Clc1ccc(cc1)NC(=O)C(=O)NC1CCC2(CCCCC2)N(C1)CCNC(=O)CCCCNC(=N)N
SMILES	CACTVS	3.385	NC(=N)NCCCCC(=O)NCCN1C[CH](CCC12CCCCC2)NC(=O)C(=O)Nc3ccc(Cl)cc3
SMILES	OpenEye OEToolkits	2.0.7	c1cc(ccc1NC(=O)C(=O)NC2CCC3(CCCCC3)N(C2)CCNC(=O)CCCCNC(=N)N)Cl
Canonical SMILES	CACTVS	3.385	NC(=N)NCCCCC(=O)NCCN1C[C@@H](CCC12CCCCC2)NC(=O)C(=O)Nc3ccc(Cl)cc3
Canonical SMILES	OpenEye OEToolkits	2.0.7	[H]/N=C(\N)/NCCCCC(=O)NCCN1C[C@@H](CCC12CCCCC2)NC(=O)C(=O)Nc3ccc(cc3)Cl
InChI	InChI	1.06	InChI=1S/C26H40ClN7O3/c27-19-7-9-20(10-8-19)32-23(36)24(37)33-21-11-14-26(12-3-1-4-13-26)34(18-21)17-16-30-22(35)6-2-5-15-31-25(28)29/h7-10,21H,1-6,11-18H2,(H,30,35)(H,32,36)(H,33,37)(H4,28,29,31)/t21-/m1/s1
InChIKey	InChI	1.06	CGZSMDJLUHVSDB-OAQYLSRUSA-N

Related Resource References

Resource Name	Reference
PubChem	166449939

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.